Dr. L. JANSSEN
ActiveDr. L. JANSSEN has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €468k and a net result of €76k. Equity is growing by ~11.5% per year across the filed fiscal years. Its solvency ranks better than 95% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
86
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability89▲+6
Solvency100=
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 34.31 against 28.52 in 2024; short-term debt: 2.7% and cash: 0.9% of total assets), and 2.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
97.3%
Return on assets
15.8%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
27 d late
2024
29 d late
2023
27 d late
2022
31 d late
2021
61 d late
2020
30 d late
2019
on the day
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€468k▲ 19.4%
2024 · €392k
2018: €181k
2019: €239k
2020: €283k
2021: €321k
2022: €408k
2023: €416k
2024: €392k
2018 → 2025
Total assets
€482k▲ 18.9%
2024 · €405k
2018: €219k
2019: €257k
2020: €298k
2021: €327k
2022: €426k
2023: €433k
2024: €405k
2018 → 2025
Net result
€76k▲ 66.8%
2024 · €46k
2018: €69k
2019: €57k
2020: €73k
2021: €38k
2022: €88k
2023: €62k
2024: €46k
2018 → 2025
Working capital
€436k▲ 22.8%
2024 · €355k
2018: €163k
2019: €221k
2020: €269k
2021: €316k
2022: €404k
2023: €374k
2024: €355k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€321k-€408k▲ 27.3%€416k▲ 1.8%€392k▼ 5.6%€468k▲ 19.4%
Operating result€52k-€121k▲ 131%€85k▼ 29.7%€62k▼ 26.6%€103k▲ 65.4%
Net result€38k-€88k▲ 132%€62k▼ 29.8%€46k▼ 25.8%€76k▲ 66.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 65% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €482k
Fixed assets
€32k▼ 12.6%
Current assets
€449k▲ 22.0%
Equity and liabilities €482k
Equity
€468k▲ 19.4%
Debt
€13k▲ 1.5%
The debt ratio falls from 3.2% to 2.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€110k▲
2024 · €68k
Cash flow
€83k▲
2024 · €52k
Solvency
97.3%▲
2024 · 96.8%
Current ratio
34.31▲
2024 · 28.52
Quick ratio
34.31▲
2024 · 28.52
Debt / equity
0.03▼
2024 · 0.03
ROE
16.3%▲
2024 · 11.6%
ROA
15.8%▲
2024 · 11.3%
Interest coverage
787.89▲
2024 · 459.98
Debt
€13k▲
2024 · €13k
Debt ≤ 1 year
€13k▲
2024 · €13k
Income taxes
€28k▲
2024 · €18k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€405k€482k▲
Fixed assets21/28€37k€32k▼
Tangible fixed assets22/27€37k€32k▼
Land and buildings22€2k€1k▼
Plant, machinery and equipment23€35k€31k▼
Current assets29/58€368k€449k▲
Amounts receivable within one year40/41€6k€65k▲
Trade receivables40-€10k
Other amounts receivable41€6k€55k▲
Current investments50/53€331k€344k▲
Cash at bank and in hand54/58€23k€4k▼
Deferred charges and accrued income490/1€9k€36k▲
Equity and liabilities
Total equity and liabilities10/49€405k€482k▲
Equity10/15€392k€468k▲
Contributions10/11€12k€12k=
Reserves13€380k€456k▲
Distributable reserves133€380k€456k▲
Amounts payable17/49€13k€13k▲
Amounts payable within one year42/48€13k€13k▲
Trade debts44€638€3k▲
Suppliers440/4€638€3k▲
Taxes, remuneration and social security45€3k€10k▲
Taxes450/3€3k€10k▲
Other amounts payable47/48€10k-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€7k▲
Other operating charges640/8€1k€5k▲
Gross operating margin9900€70k€115k▲
Operating profit (loss)9901€62k€103k▲
Financial income75/76B€1k€1k▲
Recurring financial income75€1k€1k▲
Financial charges65/66B€149€140▼
Recurring financial charges65€149€140▼
Profit (loss) for the period before taxes9903€64k€104k▲
Income taxes67/77€18k€28k▲
Profit (loss) for the period9904€46k€76k▲
Profit (loss) for the period to be appropriated9905€46k€76k▲
Appropriation of the result
Profit (loss) to be appropriated9906€46k€76k▲
Transfer from equity791/2€69k-
Transfer to equity691/2€46k€76k▲
To other reserves6921€46k€76k▲
Profit to be distributed694/7€69k-
Return on contributions (dividend)694€69k-
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
27-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 27 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Highest result since 2018net €88k ▲132%
Operating result €121k, net result €88k, both a record.
30-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 61 days late
2021
31-12
Financial
Weakest financial yearnet €38k ▼48.5%
Net result drops to €38k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity triplescurrent ratio 54.60
Current ratio from 19.40 to 54.60; short-term debt falls from €15k to €6k.
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Liquidity doublescurrent ratio 17.53
Current ratio from 7.31 to 17.53; short-term debt falls from €26k to €13k.
31-12
Financial
Equity above €200kEq €239k ▲31.7%
2 profitable years in a row build equity to €239k.
25-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 27 days late
2017
27-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lummen · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hoefstraat 103560 LummenGround area
340 m²
Building footprint
60 m²
Volume, LiDAR
300 m³
Parcel 71037C2395/00H000, Flanders · tallest building 7.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. L. JANSSEN
since 20142.227.227.292
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71037C2395/00H000 | Flanders | 340 m² | 1 · 60 m² | 7.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
VIREMED
BE 0741.597.167
Dilsen-Stokkem · Eq €468k
Cabinet Médical de la Haute Lesse
BE 0842.493.795
Tellin · Eq €468k
DR. CALLANT EWOUT
BE 0791.733.004
Gent · Eq €468k
DR. ERIK PEETERS
BE 0437.001.133
Antwerpen · Eq €469k
Centre de Médecine Héraclès
BE 0848.400.503
Binche · Eq €468k
Of 9,120 companies in sector 86210 we hold annual accounts for 6,336. 4,942 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded11-02-2014
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.